Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?

Detalles Bibliográficos
Autores principales: Bonecker, Simone, Magnago, Marina, Kaeda, Jaspal, Solza, Cristiana, Zalcberg Renault, Ilana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382567/
https://www.ncbi.nlm.nih.gov/pubmed/25818829
http://dx.doi.org/10.1016/j.bjhh.2014.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382567/
https://www.ncbi.nlm.nih.gov/pubmed/25818829
http://dx.doi.org/10.1016/j.bjhh.2014.08.003

Ejemplares similares